Overcome the challenges of Implementing New Biomarker Tests in Labs

The reasoning for this situation is complex and multifactorial some of the causes are related to the following:

• Lack of awareness of the new biomarker/test
• High cost/lack of reimbursement
• Lack of proper training/optimization in running the test in the lab
• Absence of preparation

Laboratories considering the adoption of a new biomarker test must assess its clinical utility, cost-effectiveness, and impact on patient care in comparison to existing diagnostic methods.

Additionally, they may need to provide training for laboratory staff and ensure seamless integration of the test into current laboratory information systems.

Developing a validated companion diagnostic (CDx) test aimed at identifying suitable patients for precision medicine (PM) treatment does not automatically guarantee precise detection of the appropriate patient population and subsequent delivery of treatment. In the current landscape of clinical diagnostic testing, many patients do not receive necessary tests in a timely manner, despite their availability.

Even after obtaining regulatory approval and completing technical optimization, the commercial availability of a biomarker test does not guarantee immediate uptake in laboratories. Factors such as reimbursement policies, clinician awareness and acceptance, and the availability of supporting infrastructure and resources can influence the pace of adoption.

This delay in accessing tests, and consequently treatments, is attributed to the inadequacies of the current clinical diagnostic testing landscape. This unprepared environment poses numerous challenges to the clinical implementation of CDx tests, hindering their diffusion and utilization.

To delve deeper into how data-driven engagement can address these challenges and facilitate the adoption of new biomarker tests, we invite you to join our upcoming webinar on November 13th from 1-2 PM EST: Optimize Your Physician Engagement Strategy: Data-Driven HCP Education in Precision Medicine.

This session will focus on effective strategies for leveraging data and omnichannel approaches to enhance physician engagement and lab education. By rapidly identifying and educating healthcare professionals about your precision medicine therapies, we can ensure timely awareness and understanding, ultimately driving adoption rates and improving patient access to essential testing and treatment